NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Clinical trials for NON-MUSCLE INVASIVE BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder device trial offers hope for patients who Can't have major surgery
Disease control OngoingThis study is testing a new treatment device called TAR-200, which is placed directly into the bladder, against standard chemotherapy for people with recurring high-risk bladder cancer. It's for patients who have already tried standard BCG treatment and either cannot or choose no…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New bladder cancer treatment available before full approval
Disease control APPROVED_FOR_MARKETINGThis program provides early access to TAR-200 for people with high-risk bladder cancer that hasn't spread into the muscle wall. It's for patients who have tried other treatments like BCG therapy but still have cancer, and who cannot or choose not to have their bladder surgically …
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC